Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2003
11/26/2003EP1268487B1 Tricyclic protein kinase inhibitors
11/26/2003EP1248608B1 Diacerein for use in treating psoriasis
11/26/2003EP1210073B1 Sunscreen agent for oral administration
11/26/2003EP1158859B1 Iodine preparation compositon
11/26/2003EP1107723B1 A carotenoid composition containing phytoene and phytofluene
11/26/2003EP0923546B1 Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2
11/26/2003EP0765326B1 Benzoylecgonine, ecgonine and ecgonidine derivatives
11/26/2003CN1458979A Modulating multiple lineage kinase proteins
11/26/2003CN1458974A Stimulation of cartilage growth with agonists of non-protecolytically activated thrombin receptor
11/26/2003CN1458929A Chemokine receptor binding heterocyclic compounds
11/26/2003CN1458926A Nitric oxide donors based on metallic centres
11/26/2003CN1458918A Method for preparing fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry
11/26/2003CN1458848A Preparations for coating wound
11/26/2003CN1458846A Synthetic erythropoiesis stimulating protein
11/26/2003CN1458842A 细胞活化剂 Cell activator
11/26/2003CN1457872A Quick-acting paste for burn and scald without leaving scar and its bandaging therapeutic method
11/26/2003CN1457865A Hair blackening tea for treatig early white hair and baldness and its preparing method
11/26/2003CN1457834A Detoxicating pill
11/26/2003CN1457828A Medicinal power for treating external trauma
11/26/2003CN1457819A Beautifying health composition
11/26/2003CN1457814A Medicine for curing tinea pedis
11/26/2003CN1457812A Chinese medicinal tincture for curing burn and scald and its preparing method
11/26/2003CN1457804A Adhesive plaster for curing lymph disease, red wound and lump furuncle
11/26/2003CN1128800C Pyrolo [2,3-d] pyrimidine compounds and its composition and use
11/26/2003CN1128798C Pharmaceutically active tricyclic amines
11/26/2003CN1128789C Benzocycloheptathiophene compounds
11/26/2003CN1128628C Chinese medicine for treating alopecia areata
11/26/2003CN1128619C Utilization of powder prepns. contg. hydroxypyridones treating leg ulcer and decubitus ulcers
11/26/2003CN1128614C Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and preparation containing it
11/25/2003US6653347 For therapy
11/25/2003US6653327 Cross-regulin composition of tumeric-derived tetrahydrocurcuminoids for skin lightening and protection against UVB rays
11/25/2003US6653322 Therapeutic combinations of RAR antagonists and RXR agonists and use thereof
11/25/2003US6653317 2-amino-4-alkylamino-6-alkoxypyrimidine 3-oxides
11/25/2003US6653313 1,4-dihydropyridine compounds as bradykinin antagonists
11/25/2003US6653312 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/25/2003US6653310 For therapy of disease states mediated by the chemokine, Interleukin-8 (IL-8)
11/25/2003US6653308 Anticancer agents; antidiabetic agents; antiinflammatory agents
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653292 Stimulating Th1 pattern of immune activation, cytokine production, NK lytic activity and B cell proliferation; modulating with nucleic acid sequences containing unmethylated CpG dinucleotides
11/25/2003US6653284 Keratinocyte growth factor-2 formulations
11/25/2003US6653116 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis
11/25/2003US6652856 Method for the treatment of fibrosis
11/25/2003US6652855 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
11/25/2003US6652854 Administering agents that hinder CD30/CD30L (CD30L=ligand of CD30) binding; animal model of arthritis for drug screening
11/25/2003CA2258811C Formulation for use in the prevention of pathogen induced diseases including hiv and hsv
11/20/2003WO2003095637A1 Combination of a growth factor and a protease enzyme
11/20/2003WO2003095613A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/20/2003WO2003095452A1 Substituted pyrroline kinase inhibitors
11/20/2003WO2003095424A1 Process for producing shogaol and intermediates for the synthesis thereof
11/20/2003WO2003094952A1 Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
11/20/2003WO2003094946A1 Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic acid
11/20/2003WO2003094937A1 A pharmaceutical composition for treatment of wounds containing blood plasma or serum
11/20/2003WO2003094932A1 Carbon monoxide as a biomarker and therapeutic agent
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003WO2003094910A1 Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy
11/20/2003WO2003094908A1 A pharmaceutical composition for the treatment of seborrhea containing 4-hydroxy-5-methoxy-4-[2-methyl-3(3-methyl-2-butenyl)-2-oxiranyl]-1-oxaspiro[2,5]octan-6-one
11/20/2003WO2003094881A1 Composition and the use thereof as a pharmaceutical or cosmetic formulation for external use
11/20/2003WO2003094865A1 External preparations for skin
11/20/2003WO2003094864A2 Novel polyol-glycoside compositions for the skin
11/20/2003WO2003094861A2 Bis-benzimidazoles and related compounds as potassium channel modulators
11/20/2003WO2003094859A2 Epha2 monoclonal antibodies and methods of use thereof
11/20/2003WO2003094831A2 Novel diazabicyclic biaryl derivatives
11/20/2003WO2003094830A2 Novel azacyclic ethynyl derivatives
11/20/2003WO2003087062A3 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
11/20/2003WO2003070192A9 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/20/2003WO2003066572B1 Polyamine compounds and compositions for use in conjunction with cancer therapy
11/20/2003WO2003065971A9 Non-myeloablative tolerogenic treatment with tyrphostins
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003049752A3 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
11/20/2003WO2003042357A3 Enzymes
11/20/2003WO2003037249A3 Method for inhibiting the formation of seromas using factor xiii
11/20/2003WO2003017946A3 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
11/20/2003WO2003016468A3 Antagonistic anti-htnfsf13b human antibodies
11/20/2003WO2003011217A9 Grifola extracts and methods of use thereof
11/20/2003WO2003008444A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/20/2003WO2003006447A3 Interaction inhibitors of tcf-4 with beta-catenin
11/20/2003WO2003003997A3 Use of hops or hop-malt extracts in cosmetic or dermatological preparations
11/20/2003WO2003000864A3 Nucleic acid-associated proteins
11/20/2003WO2003000699A8 Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain
11/20/2003WO2002102315A3 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
11/20/2003WO2002100420A3 Pharmaceutical zeolite-based compositions containing zinc and erythromycin, to be used in the treatment of acne
11/20/2003WO2002095011A3 Inactivation of genes of the mep pathway
11/20/2003WO2002090530A3 Kinases and phosphatases
11/20/2003WO2002088181A3 Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances
11/20/2003WO2002087583B1 Use of hiv-protease inhibitors to block cell migration and/or invasion, tissue infiltration and oedema formation
11/20/2003WO2002079249A3 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
11/20/2003WO2002062362A3 Antiviral and antibacterial composition
11/20/2003WO2002061110A8 Nucleic acid derivatives
11/20/2003WO2002038744A3 Proteases
11/20/2003US20030216586 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them
11/20/2003US20030216574 Pyrazine based inhibitors of glycogen synthase kinase 3
11/20/2003US20030216570 Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
11/20/2003US20030216481 Cyclooxygenase inhibitors; osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse
11/20/2003US20030216462 Anticancer agents; psoriasis
11/20/2003US20030216452 Method of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substitute indolealkanoic acids
11/20/2003US20030216440 Process for preparing arylacetylaminothiazoles
11/20/2003US20030216428 Sexual disorders; blood disorders; osteoporosis; bone disorders
11/20/2003US20030216420 Pharmaceutical composition for treating fecal incontinence and anal itch
11/20/2003US20030216419 Isomeric fused pyrrolocarbazoles and isoindolones
1 ... 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 ... 1065